22.69 (-%)
As of Nov 20, 2024
Source:
Arvinas, Inc. is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.
Country | United States |
Headquarters | new haven, connecticut |
Phone Number | (203) 535-1456 |
Industry | manufacturing |
CEO | John Houston, Ph.D. |
Website | www.arvinas.com |